INTERVENN
InterVenn focuses on the identification, quantification, and classification of Glycoproteomic and other PTM signals found in human blood and tissue for biomarker and target discovery. It specializes in the fields of biotechnology and life science. The company's VISTA is the first commercially available platform that can assess (serum or plasma) protein glycosylation in a site-specific manner, across thousands of peptides and glycopeptides. It was founded in 2017 and headquartered in Redwood City, California.
INTERVENN
Industry:
Biotechnology Life Science Medical
Founded:
2017-03-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.intervenn.com
Total Employee:
101+
Status:
Active
Contact:
888-706-1670
Email Addresses:
[email protected]
Total Funding:
278.09 M USD
Technology used in webpage:
Google Apps For Business GoDaddy DNS WP Engine My Salesforce
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Front Range Biosciences
Front Range Biosciences brings modern agriculture to improve reliability, efficiency, and safety for cultivators and consumers.
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Current Advisors List
Current Employees Featured
Founder
Investors List
Heritage Provider Network
Heritage Provider Network investment in Series C - InterVenn
Genoa Ventures
Genoa Ventures investment in Series C - InterVenn
Amplify Partners
Amplify Partners investment in Series C - InterVenn
SoftBank Capital
SoftBank Capital investment in Series C - InterVenn
Anzu Partners
Anzu Partners investment in Series C - InterVenn
True Ventures
True Ventures investment in Series C - InterVenn
Irving Investors
Irving Investors investment in Series C - InterVenn
Highside Capital Management
Highside Capital Management investment in Series C - InterVenn
Ojjeh Family Fund
Ojjeh Family Fund investment in Series B - InterVenn
Genoa Ventures
Genoa Ventures investment in Series B - InterVenn
Key Employee Changes
Official Site Inspections
http://www.intervenn.com Semrush global rank: 2.49 M Semrush visits lastest month: 7.1 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "InterVenn"
InterVenn Biosciences | Clinical Glycoproteomics
Sep 25, 2023 · We’ve developed the GlycoVisionâ„¢ platform to exponentially improve the speed, scope, and scale of glycoproteomic analysis - enabling new insights into biomarker discovery, …See details»
About InterVenn Biosciences
At InterVenn Biosciences, our mission is to advance a new era of personalized medicine by decoding the human glycoproteome – glycosylated proteins which are responsible for driving protein function – revealing a rich source of …See details»
Leadership Team | InterVenn Biosciences
He helped build ArcherDX into a leading global diagnostic organization, which was the first to have a Next Generation Sequencing (NGS)-based liquid biopsy companion diagnostic …See details»
InterVenn - Crunchbase Company Profile & Funding
InterVenn is a life science company unlocking the value of glycoproteomics—glycosylated proteins which are responsible for driving protein function—for the development of transformational healthcare solutions.See details»
InterVenn Biosciences - LinkedIn
We are a life science company decoding the glycoproteome to power personalized, predictive, and preventive care. | InterVenn was co-founded by Nobel Laureate Dr. Carolyn Bertozzi, world-class...See details»
InterVenn Biosciences - Org Chart, Teams, Culture & Jobs - The Org
View InterVenn Biosciences' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
InterVenn Biosciences Enters Next Stage with Senior …
Jan 5, 2023 · InterVenn is a life science company unlocking the value of glycoproteomics—glycosylated proteins which are responsible for driving protein function—for the development of transformational...See details»
InterVenn Company Profile 2024: Valuation, Funding & Investors
Developer of a biomarker and target discovery platform designed to help in the detection and triaging of ovarian and other cancers.See details»
InterVenn Biosciences' CEO and Executive Team - The Org
The executive team at InterVenn Biosciences has a history of experience in a variety of industries, including founding and working at companies such as Veem, Jukin Media, and Verego.com.See details»
Services | InterVenn Biosciences
InterVenn has created the first knowledge graph of its kind, combining InterVenn’s glycoproteomic data along with highly curated, public datasets (genomics, proteomics, pathways, publications, and clinical trials) to provide unique …See details»
InterVenn Biosciences Welcomes Accomplished Diagnostics
Sep 27, 2023 · InterVenn Biosciences, the life sciences company pioneering glycoproteomic-based diagnostics, announced that Joshua Stahl has been appointed as Chief Executive …See details»
InterVenn Biosciences | LinkedIn
May 5, 2019 · We are a life science company decoding the glycoproteome to power personalized, predictive, and preventive care. | InterVenn was co-founded by Nobel Laureate Dr. Carolyn …See details»
InterVenn Expands Global Presence to Drive the Potential of ...
Jul 21, 2022 · InterVenn is pioneering a new AI-powered platform to decode and unlock the potential of the glycoproteome at clinically meaningful scale for the first time in history.See details»
Jeremy Franzen - Vice President Technology Operations at …
Jeremy is currently working as the Vice President of Technology Operations at InterVenn Biosciences. Prior to this, Jeremy served as a Marine in the National Marine Corps Business …See details»
InterVenn | South San Francisco CA - Facebook
InterVenn, South San Francisco, California. 729 likes · 4 were here. InterVenn is a patient-driven, employee-first organization looking at disease in a radically different manner.See details»
InterVenn Biosciences quintuples funding with $201M for AI …
Aug 2, 2021 · Joining the ranks of the year’s most successful fundraisers so far is InterVenn Biosciences, which—like Grail, Freenome, Thrive Earlier Detection and so many others before …See details»
InterVenn Biosciences Enters Next Stage with Senior Management …
Jan 5, 2023 · “InterVenn is entering an important new phase of our development, commercialization strategy, and execution to scale the business, increase value creation and …See details»
Contact | InterVenn Biosciences
"GlycoVision results featured at ESMO 2024: read the interview here to learn how InterVenn is powering new prognostic and predictive biomarkers!See details»
InterVenn Raises $34M To Commercialize Ovarian Cancer …
Jan 7, 2021 · InterVenn Biosciences has raised $34M to commercialize a new diagnostic tool for ovarian cancer, based on the identification of circulating glycoproteins.See details»
Careers | InterVenn Biosciences
We believe that no one should be blindsided by disease. That’s why we strive to use the exploration of glycoproteomics to transform the landscape of diagnostics. There are no …See details»